Observation of Benefits for Patients Implanted With a Hearing Implant of the Company Cochlear
Launched by COCHLEAR · Dec 3, 2013
Trial Information
Current as of August 27, 2025
Terminated
Keywords
ClinConnect Summary
The clinical investigation is designed as a prospective repeated measures longitudinal study with intra-subject controls, using a selection of subjective evaluation tools to assess patient related benefits from hearing implant treatment of permanent hearing loss.
Clinically standard self-assessment scales, threshold measures and a general hearing history profile questionnaires for the clinician and implant recipient are made available for selection through an interface to a central electronic platform.
The registry is aimed at collection of data for patients who have already made the deci...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Post-lingually deafened adults and adolescents who are newly implanted AND prior to first switch-on of their external device
- • Unilateral, bilateral simultaneous recipients of any implant device(s) available with market approval from the company Cochlear®
- • Children 10 years or older and in accordance with local regulations and product labelling
- • Mentally capable to respond to self-administered assessment scales
- • Willingness to participate and sign the Patient Informed Consent form
- Exclusion Criteria:
- • Individuals excluded from participation in a registry according to national or local regulations
About Cochlear
Cochlear Limited is a global leader in implantable hearing solutions, dedicated to transforming the lives of individuals with hearing loss through innovative technology and comprehensive clinical research. With a strong commitment to advancing auditory rehabilitation, Cochlear conducts rigorous clinical trials aimed at evaluating the safety and efficacy of its products, including cochlear implants and bone conduction devices. The company collaborates with healthcare professionals and research institutions worldwide to ensure that its solutions meet the highest standards of quality and performance, ultimately enhancing patient outcomes and promoting accessibility to hearing health care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Sebastian, , Spain
Lille, , France
Nijmegen, , Netherlands
Madrid, , Spain
Barcelona, , Spain
Hannover, Niedersachsen, Germany
Leuven, , Belgium
Szeged, , Hungary
Ulm, , Germany
Alzira, , Spain
Valencia, , Spain
Caceres, , Spain
Bialystok, , Poland
Lublin, , Poland
Madrid, , Spain
Salamanca, , Spain
Zaragoza, , Spain
Porto, , Portugal
Cape Town, , South Africa
Buenos Aires, , Argentina
Buenos Aires, , Argentina
Caba, , Argentina
Córdoba, , Argentina
St. Pölten, , Austria
Sao Paulo, , Brazil
Antioquia, , Colombia
Barranquilla, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogota, , Colombia
Bogotá, , Colombia
Bogotá, , Colombia
Bogotá, , Colombia
Bogotá, , Colombia
Cali, , Colombia
Cartagena, , Colombia
Ibague, , Colombia
Manizales, , Colombia
Manizales, , Colombia
Quindio, , Colombia
Risaralda, , Colombia
Santander, , Colombia
Zipaquira, , Colombia
Bad Aibling, , Germany
Essen, , Germany
Frankfurt Am Main, , Germany
Freiburg, , Germany
Güstrow, , Germany
Münich, , Germany
Tübingen, , Germany
Wuerzburg, , Germany
Bydgoszcz, , Poland
Bydgoszcz, , Poland
Kajetany, , Poland
Konin, , Poland
Lodz, , Poland
Lodz, , Poland
Opole, , Poland
Poznan, , Poland
Szczecin, , Poland
Lisbon, , Portugal
Lisbon, , Portugal
Maribor, , Slovenia
Durban, , South Africa
Johannesburg, , South Africa
Pamplona, , Spain
Valladolid, , Spain
Stockholm, , Sweden
Eskisehir, , Turkey
Istanbul, , Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Bart Volckaerts
Study Director
Cochlear
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials